A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells
- 27 February 2018
- journal article
- research article
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 72 (3) , 615-625
Abstract
Failure of current chemotherapeutic drugs leads to the recurrence of tumor pathology and mortality in lung cancer patients. This study aimed to evaluate the anticancer activity and related mechanisms of 4,5,4′-trihydroxy-3,3′-dimethoxybibenzyl (TDB), a bibenzyl extracted from Dendrobium ellipsophyllum Tang and Wang, in human lung cancer cells. Cytotoxicity of TDB (0–300 µM) in different types of human lung cancer cells (H460, H292 and H23) and human dermal papilla cells (DPCs) was evaluated via MTT viability assay. Selective anticancer activity of TDB against human lung cancer cells was demonstrated with a high IC50 (approximately > 300 µM) in DPCs, while IC50 in human lung cancer H460, H292 and H23 cells was approximately 100 ± 5.18, 100 ± 8.73 and 188.89 ± 8.30 µM, respectively. After treatment with 50 µM of TDB for 24 h, flow cytometry analysis revealed the significant increase of early and late apoptosis with absence of necrosis cell death in human lung cancer cells. The up-regulation of p53, a tumor-suppressor protein, was elucidated in human lung cancer cells treated with 10–50 µM of TDB. Alteration to down-stream signaling of p53 including activation of pro-apoptosis protein (Bcl-2-associated X protein; Bax), reduction of anti-apoptosis (B cell lymphoma 2; Bcl-2 and myeloid cell leukemia 1; Mcl-1) and suppression on protein kinase B (Akt) survival pathway were notified in TDB-treated lung cancer cells. The information obtained from this study strengthens the potential development of TDB as an anticancer compound with a favorable human safety profile and high efficacy.Keywords
Funding Information
- Chulalongkorn University (New Scholar Ratchadaphiseksomphot Endowment Fund Chulalongkorn University, Scholarship of 60/40 Support for Tuition Fee from Graduate School)
This publication has 62 references indexed in Scilit:
- The Biological Role of PI3K Pathway in Lung CancerPharmaceuticals, 2012
- Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated PathwaysPLOS ONE, 2011
- Apoptotic cell signaling in cancer progression and therapyIntegrative Biology, 2011
- p53-based Cancer TherapyCold Spring Harbor Perspectives in Biology, 2010
- Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular SpheroidsAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteinsProceedings of the National Academy of Sciences, 2008
- PUMA, a potent killer with or without p53Oncogene, 2008
- Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cellsBiochemical Pharmacology, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Differential contribution of Puma and Noxa in dual regulation of p53‐mediated apoptotic pathwaysThe EMBO Journal, 2006